These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27939481)

  • 1. Aspirin adherence during high-risk pregnancies, a questionnaire study.
    Abheiden CN; van Reuler AV; Fuijkschot WW; de Vries JI; Thijs A; de Boer MA
    Pregnancy Hypertens; 2016 Oct; 6(4):350-355. PubMed ID: 27939481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using extended theory of planned behavior to understand aspirin adherence in pregnant women.
    Lin CY; Broström A; Nilsen P; Pakpour AH
    Pregnancy Hypertens; 2018 Apr; 12():84-89. PubMed ID: 29674206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Influence of Nonadherence With Prophylactic Aspirin in Preventing Preeclampsia in High-Risk Pregnancies: A Multicenter, Prospective, Observational Cohort Study.
    Shanmugalingam R; Wang X; Motum P; Fulcher I; Lee G; Kumar R; Hennessy A; Makris A
    Hypertension; 2020 Apr; 75(4):1125-1132. PubMed ID: 32114852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin non-responsiveness in pregnant women at high-risk of pre-eclampsia.
    Navaratnam K; Alfirevic A; Jorgensen A; Alfirevic Z
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():144-150. PubMed ID: 29304392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis.
    Shanmugalingam R; Mengesha Z; Notaras S; Liamputtong P; Fulcher I; Lee G; Kumar R; Hennessy A; Makris A
    PLoS One; 2020; 15(2):e0229622. PubMed ID: 32106237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia.
    Karunia RI; Purnamayanti A; Prasetyadi FOH
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31927518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aspirin: Indications and use during pregnancy].
    Belhomme N; Doudnikoff C; Polard E; Henriot B; Isly H; Jego P
    Rev Med Interne; 2017 Dec; 38(12):825-832. PubMed ID: 29129461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health literacy and its association with perception of teratogenic risks and health behavior during pregnancy.
    Lupattelli A; Picinardi M; Einarson A; Nordeng H
    Patient Educ Couns; 2014 Aug; 96(2):171-8. PubMed ID: 24862909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is testing for aspirin response worthwhile in high-risk pregnancy?
    Rey E; Rivard GE
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):38-42. PubMed ID: 21440360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT.
    van Hoorn ME; Hague WM; van Pampus MG; Bezemer D; de Vries JI;
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():168-73. PubMed ID: 26771908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' perspective on aspirin during pregnancy: a survey.
    Bij de Weg JM; Abheiden CNH; de Boer MA; de Groot C; de Vries JIP
    Hypertens Pregnancy; 2020 Nov; 39(4):371-378. PubMed ID: 32564638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis.
    Roberge S; Nicolaides KH; Demers S; Villa P; Bujold E
    Ultrasound Obstet Gynecol; 2013 May; 41(5):491-9. PubMed ID: 23362106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of high risk of non-adherence to antiplatelet treatment.
    Kubica A; Obońska K; Kasprzak M; Sztuba B; Navarese EP; Koziński M; Świątkiewicz I; Kieszkowska M; Ostrowska M; Grześk G; Kubica J
    Kardiol Pol; 2016; 74(1):61-7. PubMed ID: 26101025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-adherence to aspirin in patients undergoing coronary stenting: negative impact of comorbid conditions and implications for clinical management.
    Cuisset T; Quilici J; Fugon L; Cohen W; Roux P; Gaborit B; Molines L; Fourcade L; Bonnet JL; Carrieri P
    Arch Cardiovasc Dis; 2011 May; 104(5):306-12. PubMed ID: 21693367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of a mobile educative Application additional to Standard counselling on aspirin Adherence in Pregnancy: the ASAP study, a randomised controlled trial.
    Bij de Weg JM; de Boer MA; Meijer C; Lugtenburg N; Melles M; de Vries JIP; de Groot CJM
    PEC Innov; 2024 Dec; 4():100268. PubMed ID: 38435238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric index in the primary prevention of hypertensive complications in high-risk pregnancy.
    Otero González A; Uribe Moya S; Arenas Moncaleano IG; Borrajo Prol MP; García García MJ; López Sánchez L
    Nefrologia; 2015; 35(6):572-7. PubMed ID: 26547790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titration of antiplatelet treatment in pregnant women at risk of preeclampsia.
    Sullivan MH; Clark NA; de Swiet M; Nelson-Piercy C; Elder MG
    Thromb Haemost; 1998 Apr; 79(4):743-6. PubMed ID: 9569185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia - A qualitative study.
    Vinogradov R; Smith VJ; Robson SC; Araujo-Soares V
    Pregnancy Hypertens; 2021 Aug; 25():161-168. PubMed ID: 34147883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-specific factors relating to medication adherence in a post-percutaneous coronary intervention cohort.
    Rushworth GF; Cunningham S; Mort A; Rudd I; Leslie SJ
    Int J Pharm Pract; 2012 Aug; 20(4):226-37. PubMed ID: 22775519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.